MIRA INFORM REPORT

 

 

Report No. :

316162

Report Date :

06.04.2015

 

IDENTIFICATION DETAILS

 

Name :

SALUTAS PHARMA GMBH

 

 

Registered Office :

Otto-von-Guericke-Allee 1, D 39179 Barleben

 

 

Country :

Germany

 

 

Date of Incorporation :

21.12.1990

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

·         Manufacture of pharmaceutical preparations

·         Wholesale of pharmaceutical, medical and orthpedic goods

 

 

No. of Employees :

1,400

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Germany

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

GERMANY - ECONOMIC OVERVIEW

 

The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, has contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.3% in 2013. The new German government introduced a minimum wage of $11 per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production.

 

Source : CIA

 

 

Comapny name & address

 

SALUTAS PHARMA GMBH

 

 Company Status:         active

                                    Otto-von-Guericke-Allee 1

                                    D 39179 Barleben

                                    Telephone:039203/710

                                    Telefax:  039203/717770

                                    Homepage: www.salutas.de

                                    E-mail:   info.salutas@sandoz.com

 

 VAT no.:                      DE139235165

 

 

CONCLUSION

 

 Business relations are permissible.

 

 LEGAL FORM           Private limited company

 Date of foundation:  21.12.1990

 Shareholders'

 agreement:           21.12.1990

 Registered on:       13.08.1993

 Commercial Register: Local court 39576 Stendal

 under:               HRB 105793

 

 Share capital:                          EUR         42,100,000.00

 

 Shareholder:

                      H e x a l Aktiengesellschaft

                      Industriestr. 25

                      D 83607 Holzkirchen

                      Legal form: Public limited company

                      Share capital:     EUR         93,694,237.23

                      Share:             EUR         42,100,000.00

                      Registered on: 03.08.1995

                      Reg. data: 80333 München, HRB 110375

                      Control and profit transfer agreement

 Manager:

                      Norbert Marquardt

                      Ahrensfelder Weg 9

                      D 22927 Großhansdorf

                      born: 24.05.1958

 Manager:

                      Burkart Gert Broede

                      D 20095 Hamburg

                      born: 01.10.1974

 Manager:

                      Jeffrey Simon Francis

                      D 65033 Wiesbaden

                      born: 11.12.1971

 Proxy:

                      Gerhard Bauer

                      D 38350 Helmstedt

                      authorized to jointly represent the company

                      born: 24.05.1961

 Proxy:

                      Sabine Austermann

                      D 38100 Braunschweig

                      authorized to jointly represent the company

 Proxy:

                      Gert Magnus Baron von Stackelberg

                      D 10115 Berlin

                      authorized to jointly represent the company

                      born: 29.04.1950

 Proxy:

                      Norman Scheider

                      Salvador-Allende-Str. 2

                      D 39126 Magdeburg

                      authorized to jointly represent the company

                      born: 09.12.1970

 Proxy:

                      Cathleen Filor

                      D 39291 Möser

                      authorized to jointly represent the company

 Proxy:

                      Dr. Irmgard Neuper

                      D 71229 Leonberg

                      authorized to jointly represent the company

                      born: 04.03.1970

 Proxy:

                      Fred Wulfgramm

                      Schneppruthe 18

                      D 51469 Bergisch Gladbach

                      authorized to jointly represent the company

                      born: 10.09.1962

 Proxy:

                      Lutz Rüdiger Springer

                      D 22962 Siek

                      authorized to jointly represent the company

                      born: 29.08.1963

 Proxy:

                      Notker Walter Karpf

                      D 55437 Ockenheim

                      authorized to jointly represent the company

                      born: 12.02.1963

 Proxy:

                      Jörg Ullrich Schöfthaler

                      D 90562 Heroldsberg

                      authorized to jointly represent the company

                      born: 21.01.1966

 

 

RESIGNED ACTING PERSONS AND SHAREHOLDERS

 

 02.09.2011 - 26.06.2014  Manager

                          Thomas Alexander Baur

                          D 35037 Marburg

 

 

BUSINESS ACTIVITIES

 

 Main industrial sector

 21200  Manufacture of pharmaceutical preparations

4646    Wholesale of pharmaceutical, medical and orthpedic goods

 

 

BRANCHES AND FACTORIES

 

 Works:

                      Salutas Pharma GmbH

                      Lange Göhren 3

                      D 39171 Sülzetal

                      TEL.: 039205/421000

                      FAX.: 039205/421240

 Branch:

                      Salutas Pharma GmbH

                      Dieselstr. 5

                      D 70839 Gerlingen

 

 Payment experience:  within agreed terms

 

 Negative information:We have no negative information at hand.

 

 

REAL ESTATE

 

 Type of ownership:   Beneficiary

 Address              Otto-von-Guericke-Allee 1

                      D 39179 Barleben

 Type of real estate: factory building

 

 Type of ownership:   Tenant

 Address              Lange Göhren 3

                      D 39171 Sülzetal

 

 Land register documents were not available.

 

 

BANKERS

 

 Principal bank

 COMMERZBANK VORMALS DRESDNER BANK, 39003 MAGDEBURG

 Sort. code: 81080000

 BIC: DRESDEFF810

 

 Further banks

 DEUTSCHE BANK, 39001 MAGDEBURG

 Sort. code: 81070000

 BIC: DEUTDE8MXXX

 UNICREDIT BANK - HYPOVEREINSBANK, 80311 MÜNCHEN

 Sort. code: 70020270

 BIC: HYVEDEMMXXX

 

 

FINANCIAL FIGURES

 

 Financial year:      01.01. - 31.12.

 Turnover:            2013               EUR        900,000,000.00

                          2014               EUR        900,100,000.00

 further business figures:

 Share capital:                          EUR         42,100,000.00

 Equipment:                             *EUR          8,208,000.00

 Ac/ts receivable:                      *EUR          9,576,000.00

 Liabilities:                           *EUR         23,940,000.00

 Employees:                                                  1,400

 - Trainees:                                                    32

 

 Control and profit transfer agreement to:

                      H e x a l Aktiengesellschaft

                      Industriestr. 25

                      D 83607 Holzkirchen

 

 The business figures marked with an asterisk are estimates based on average values in the line of business.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.59

UK Pound

1

Rs.92.46

Euro

1

Rs.67.51

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ASH

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.